Incannex Healthcare Inc. (IXHL)Healthcare | Drug Manufacturers - Specialty & Generic | Sydney, Australia | NasdaqCM
3.64 USD
-0.05
(-1.355%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.66 +0.02 (0.549%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:57 a.m. EDT
The investment case for Incannex Healthcare is currently broken by a catastrophic multi-year decline. The stock has lost 97% of its value over the last three years, with every single year showing double-digit percentage losses. This is not a temporary correction; it is a structural implosion where the market has repeatedly rejected the business model. Despite a technically pristine balance sheet with negligible debt and massive cash reserves relative to liabilities, the company is burning cash aggressively, posting negative free cash flow and negative returns on equity. The recent 1-for-30 reverse stock split, while intended to regain compliance, often signals distress and can trigger further selling pressure as retail investors exit. While the patent protection for its sleep apnea drug offers a theoretical long-term moat, the execution history is non-existent. There is no dividend to provide income, and the statistical models offer no guidance for a recovery. Until the company demonstrates a sustained path to profitability or a clear turnaround in revenue growth, this remains a speculative trap for capital preservation. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.087878 |
| AutoTheta | 0.093601 |
| AutoETS | 0.098421 |
| AutoARIMA | 0.467783 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 39% |
| H-stat | 0.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.246 |
| Excess Kurtosis | -0.94 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.152 |
| Market Cap | 43,550,976 |
| Forward P/E | -2.10 |
| Beta | 2.81 |
| Previous Name | Incannex Healthcare Limited |
| Website | https://www.incannex.com |
As of Aug. 22, 2026, 5:57 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside participation. Put open interest is concentrated deep in-the-money at the $1 strike, while call activity is sparse and mostly centered at the money or slightly out-of-the-money. The implied volatility skew shows significantly higher pricing for downside protection compared to upside bets, indicating a market consensus focused on capital preservation given the recent volatility and reverse split events.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.80721 |
| Address1 | 8 Century Circuit |
| Address2 | Suite 105 Norwest |
| All Time High | 11,528.4 |
| All Time Low | 2.4 |
| Ask | 4.6 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 93,850 |
| Average Daily Volume3 Month | 200,193 |
| Average Volume | 200,193 |
| Average Volume10Days | 93,850 |
| Beta | 2.805 |
| Bid | 2.62 |
| Bid Size | 2 |
| Book Value | 5.498 |
| City | Sydney |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Australia |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.64 |
| Current Ratio | 41.565 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.785 |
| Day Low | 3.58 |
| Debt To Equity | 0.152 |
| Display Name | Incannex Healthcare |
| Earnings Timestamp End | 1,747,310,403 |
| Earnings Timestamp Start | 1,747,310,403 |
| Ebitda | -24,695,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 1.247 |
| Enterprise Value | -30,785,024 |
| Eps Current Year | -2.475 |
| Eps Forward | -1.7295818 |
| Eps Trailing Twelve Months | -16.31 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.3269 |
| Fifty Day Average Change | 0.3131001 |
| Fifty Day Average Change Percent | 0.094111666 |
| Fifty Two Week Change Percent | -80.721 |
| Fifty Two Week High | 20.64 |
| Fifty Two Week High Change | -17.0 |
| Fifty Two Week High Change Percent | -0.82364345 |
| Fifty Two Week Low | 2.49 |
| Fifty Two Week Low Change | 1.1500001 |
| Fifty Two Week Low Change Percent | 0.46184742 |
| Fifty Two Week Range | 2.49 - 20.64 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,646,231,400,000 |
| Float Shares | 9,596,410 |
| Forward Eps | -1.7295818 |
| Forward P E | -2.104555 |
| Free Cashflow | -8,271,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Fullday Change | -0.05 |
| Fullday Change Percent | -1.35501 |
| Fullday Price | 3.66 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | 0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.123380005 |
| Held Percent Institutions | 0.03814 |
| Implied Shares Outstanding | 11,964,554 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ipo Expected Date | 2,022-02-25 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,751,241,600 |
| Last Split Date | 1,772,150,400 |
| Last Split Factor | 1:30 |
| Long Business Summary | Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia. |
| Long Name | Incannex Healthcare Inc. |
| Market | us_market |
| Market Cap | 43,550,976 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_325166139 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -48,414,000 |
| Next Fiscal Year End | 1,782,777,600 |
| Non Diluted Market Cap | 44,388,495 |
| Number Of Analyst Opinions | 1 |
| Open | 3.7 |
| Operating Cashflow | -17,723,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 61 4 0984 0786 |
| Post Market Change | 0.01999998 |
| Post Market Change Percent | 0.54945 |
| Post Market Price | 3.66 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Incannex Healthcare Limited |
| Previous Close | 3.69 |
| Price Eps Current Year | -1.4707072 |
| Price Hint | 4 |
| Price To Book | 0.66205895 |
| Price To Sales Trailing12 Months | Infinity |
| Profit Margins | 0.0 |
| Quick Ratio | 41.469 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.049999952 |
| Regular Market Change Percent | -1.3550122 |
| Regular Market Day High | 3.785 |
| Regular Market Day Low | 3.58 |
| Regular Market Day Range | 3.58 - 3.785 |
| Regular Market Open | 3.7 |
| Regular Market Previous Close | 3.69 |
| Regular Market Price | 3.64 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 42,732 |
| Return On Assets | -0.32187 |
| Return On Equity | -1.1717299 |
| Revenue Per Share | 0.0 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 11,964,554 |
| Shares Percent Shares Out | 0.0679 |
| Shares Short | 812,491 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,004,775 |
| Short Name | Incannex Healthcare Inc. |
| Short Percent Of Float | 0.0688 |
| Short Ratio | 7.46 |
| Source Interval | 15 |
| State | NSW |
| Symbol | IXHL |
| Target High Price | 18.23757 |
| Target Low Price | 18.23757 |
| Target Mean Price | 18.23757 |
| Target Median Price | 18.23757 |
| Total Cash | 74,450,000 |
| Total Cash Per Share | 6.223 |
| Total Debt | 114,000 |
| Total Revenue | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -16.31 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.109075 |
| Two Hundred Day Average Change | -2.469075 |
| Two Hundred Day Average Change Percent | -0.40416512 |
| Type Disp | Equity |
| Volume | 42,732 |
| Website | https://www.incannex.com |
| Zip | 2,153 |